GMAB

E854985

GMAB is the stock ticker symbol for Genmab A/S, a Danish biotechnology company specializing in the development of antibody-based cancer therapies.

All labels observed (1)

Label Occurrences
GMAB canonical 3

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf biotechnology company
monoclonal antibody
stock ticker symbol
coreBusiness research and development of antibody therapeutics
country Denmark
currency Danish krone
developedBy Genmab A/S
linked to: Genmab
develops antibody-drug conjugates
bispecific antibodies
monoclonal antibody therapeutics
focusesOn immuno-oncology
oncology
foundedBy Florian Schönharting
Jan G. J. van de Winkel
Medarex, Inc.
foundingYear 1999
hasADR GMAB
hasCollaborationWith AbbVie
BioNTech
Janssen Biotech
Roche
Seagen
headquartersLocation Copenhagen, Denmark
linked to: Copenhagen
indication multiple myeloma
industry biotechnology
pharmaceuticals
ISIN DK0010272202
DK0010272202
legalForm Aktieselskab
listedAs GMAB
listedOn NASDAQ Global Select Market
marketedAs Darzalex
notableProduct daratumumab
primaryListing NASDAQ Copenhagen
represents Genmab A/S
linked to: Genmab
secondaryListing NASDAQ Global Select Market
securityType equity
segment large-cap biotech
specializesIn antibody-based cancer therapies
technologyPlatform antibody discovery platform
tradesOn NASDAQ Copenhagen
NASDAQ Global Select Market
treatsDiseaseArea hematologic malignancies
solid tumors
underlyingCompany Genmab A/S
linked to: Genmab
website https://www.genmab.com

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Genmab tickerSymbol GMAB
Genmab A/S hasADR GMAB
subject linked to: GMAB
Genmab A/S listedAs GMAB
subject linked to: GMAB